Renovascular hypertension: An update

Journal of Clinical Hypertension

Volumn 10, Issue 7, 2008, Pages 522-533

  Elliott, William J ^a  

^a RUSH MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IODOHIPPURATE SODIUM I 121; MERTIATIDE TC 99M; PENTETATE TECHNETIUM TC 99M; RADIOISOTOPE; UNCLASSIFIED DRUG; ANGIOTENSIN RECEPTOR ANTAGONIST;

ANGIOPLASTY; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOPPLER ECHOGRAPHY; FIBROMUSCULAR DYSPLASIA; GLYCEMIC CONTROL; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INVASIVE PROCEDURE; KIDNEY ARTERY STENOSIS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY SCINTISCANNING; MAGNETIC RESONANCE ANGIOGRAPHY; NEPHROSCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RENAL ARTERY ANEURYSM; RENOVASCULAR HYPERTENSION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SCREENING; SIDE EFFECT; SMOKING CESSATION; STENT; TREATMENT OUTCOME; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RISK FACTOR; UNITED STATES;

ANGIOPLASTY, BALLOON; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, RENOVASCULAR; MAGNETIC RESONANCE ANGIOGRAPHY; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 54449093633     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1751-7176.2008.07788.x     Document Type: Review

References (50)

1. Alcazar JM, Rodicio JL. European Society of Hypertension: How to handle renovascular hypertension. J Hypertens. 2001;19:2109-2111.
2. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. Hypertension. 2003;42:1206-1252.
3. Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. 2001;344:431-442.
4. Hirsch AT, Haskal ZJ, Hertzer NR, et al; American Association for Vascular Surgery; Society for Vascular Surgery; Society for Cardiovascular Angiography and Interventions; Society for Vascular Medicine and Biology; Society of Interventional Radiology; ACC/AHA Task Force on Practice Guidelines Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease; American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; Vascular Disease Foundation. ACC/ AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology
5. Kerut EK, Geraci SA, Falterman C, et al. Atherosclerotic renal artery stenosis and renovascular hypertension: Clinical diagnosis and indications for revascularization. J Clin Hypertens (Greenwich). 2006;8:502-509.
6. White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation. 2006;113:1464-1473.
7. Textor SC. Renovascular hypertension update. Curr Hypertens Rep. 2006;8:521-527.
8. Bloch MJ, Basile J. Diagnosis and management of renovascular disease and renovascular hypertension. J Clin Hypertens (Greenwich). 2007;9:381-389.
9. Glodny B, Glodny D. John Loesch, discoverer of renovascular hypertension, and Harry Goldblatt: Two great pioneers in circulation research. Ann Intern Med. 2006;144:286-295.
10. White CJ, Jaff MR, Haskal ZJ, et al. Indications for renal arteriography at the time of coronary arteriography: A science advisory from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology, and the Councils on Cardiovascular Radiology and Intervention and on Kidney in Cardiovascular Disease. Circulation. 2006;114:1892-1895.
11. Slovut DP, Olin JW. Current concepts: Fibromuscular dysplasia. N Engl J Med. 2004;350:1862-1871.
12. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis. Kidney Int. 2005;68:293-301.
13. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362-1374.
14. Caps MT, Zierler RE, Polissar NL, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int. 1998;53:735-742.
15. Edwards MS, Craven TE, Burke GL, et al. Renovascular disease and the risk of adverse coronary events in the elderly: A prospective, population-based study. Arch Intern Med. 2005;165:207-213.
16. Shafique S, Peixoto AJ. Renal artery stenosis and cardiovascular risk. J Clin Hypertens (Greenwich). 2007;9:201-208.
17. Levin A, Linas S, Luft FC, et al. Controversies in renal artery stenosis: A review by the American Society of Nephrology Advisory Group on Hypertension. Am J Nephrol. 2007;27:212-220.
18. Krijnen P, Steyerberg EW, Postma CT, et al. Validation of a prediction rule for renal artery stenosis. J Hypertens. 2005;23:1583-1588.
19. Vasbinder GB, Nelemans PJ, Kessels AG, et al. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: A meta-analysis. Ann Intern Med. 2001;135:401-411.
20. Vasbinder GBC, Nelemans PJ, Kessels AGH, et al. Accuracy of computed tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Renal Artery Diagnostic Imaging Study in Hypertension (RADISH) Study Group. Ann Intern Med. 2004;141:674-682.
21. Elliott WJ. Comparison of sensitivity and specificity for four screening tests for renal artery stenosis: A literature review [abstract]. Am J Hypertens. 2005;18:239A.
22. Taylor AT Jr, Fletcher JW, Nally JV Jr, et al. Procedure guideline for diagnosis of renovascular hypertension: Society of Nuclear Medicine. J Nucl Med. 1998;39:1297-1302.
23. Taylor A. Renovascular hypertension: Nuclear medicine techniques. Q J Nucl Med. 2002;46:268-282.
24. Van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med. 2000;342:1007-1014.
25. Radermacher J, Chavan J, Bleck J, et al. Use of Doppler ultrasound to predict the outcome of therapy for renal artery stenosis. N Engl J Med. 2001;344:410-417.
26. Bolduc JP, Oliva VL, Therasse E, et al. Diagnosis and treatment of renovascular hypertension: A cost-benefit analysis. AJR Am J Roentgenol. 2005;184:931-937.
27. Qanadli SD, Soulez G, Therasse E, et al. Detection of renal artery stenosis: Prospective comparison of captopril-enhanced Doppler sonography, captopril-enhanced scintigraphy, and MR angiography. AJR Am J Roentgenol. 2001;177:1123-1129.
28. Eklof H, Ahlstrom H, Magnusson A, et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol. 2006;47:764-774.
29. Binkert CA, Debatin JF, Schneider E, et al. Can MR measurement of renal artery flow and renal volume predict the outcome of percutaneous transluminal renal angioplasty? Cardiovasc Intervent Radiol. 2001;24:233-239.
30. Carlos RC, Axelrod DA, Ellis JH, et al. Incorporating patient-centered outcomes in the analysis of cost-effectiveness: Imaging strategies for renovascular hypertension. AJR Am J Roentgenol. 2003;181:1653-1661.
31. Sung CK, Chung JW, Kim SH, et al. Urine attenuation ratio: A new CT indicator of renal artery stenosis. AJR Am J Roentgenol. 2006;187:532-540.
32. Gowda MS, Loeb AL, Crouse LJ, et al. Complementary roles of color-flow duplex imaging and intravascular ultrasound in the diagnosis of renal artery fibromuscular dysplasia: Should renal arteriography serve as the "gold standard?"J Am Coll Cardiol. 2003;41:1305-1311.
33. Mitchell JA, Subramanian R, White CJ, et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: renal fractional flow reserve. Catheter Cardiovasc Interv. 2007;69:685-689.
34. Rigatelli G. Renovascular disease imaging: Today more than ever the invasive cardiologist may make the difference. Int J Cardiol. 2006;113:149-152.
35. Buller CE, Nogareda JG, Ramanathan K, et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol. 2004;43:1606-1613.
36. ChábováV, Schirger A, Stanson AW, et al. Outcomes of atherosclerotic renal artery stenosis managed without revascularization. Mayo Clin Proc. 2000;75:437-444.
37. Pillay WR, Kan YM, Crinnion JN, et al. Prospective multicentre study of the natural history of atherosclerotic renal artery stenosis in patients with peripheral vascular disease. Br J Surg. 2002;89:737-740.
38. Balk E, Raman G, Chung M, et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med. 2006;145:901-912.
39. Alhadad A, Mattiasson I, Ivancev K, et al. Revascularisation of renal artery stenosis caused by fibromuscular dysplasia: Effects on blood pressure during 7-year follow-up are influenced by duration of hypertension and branch artery stenosis. J Hum Hypertens. 2005;19:761-767.
40. Gray BH. Intervention for renal artery stenosis: Endovascular and surgical roles. J Hypertens Suppl. 2005;23(3):S23-S29.
41. Galaria II, Surowiec SM, Rhodes JM, et al. Percutaneous and open renal revascularizations have equivalent long-term functional outcomes. Ann Vasc Surg. 2005;19:218-228.
42. van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet. 1999;353:282-286.
43. Dorros G, Jaff M, Mathiak L, et al. Multicenter Palmaz stent renal artery stenosis revascularization registry report: Four-year follow-up of 1068 successful patients. Catheter Cardiovasc Interv. 2002;55:182-188.
44. Bax L, Mali WP, Buskens E, et al. The benefit of Stent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal Artery. The STAR-study: Rationale and study design. J Nephrol. 2003;16:807-817.
45. Mistry S, Ives N, Harding J, et al, on behalf of the ASTRAL Collaborative Group. Angioplasty and Stent for Renal Artery Lesions (ASTRAL) trial: Rationale, methods and resuls so far. J Hum Hypertens. 2007;21:511-515.
46. Cooper CJ, Murphy TP, Matsumoto A, et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial. Am Heart J. 2006;152:59-66.
47. Nordmann AJ, Wood K, Parkes R, et al. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am J Med. 2003;114:44-50.
48. Ives NJ, Wheatley K, Stowe RL, et al. Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: A meta-analysis of randomized trials. Nephrol Dial Transplant. 2003;18:298-304.
49. Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension. 1998;31:823-829.
50. Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs. continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens. 1998;12:329-335.